Potential of transposon-mediated cellular reprogramming towards cell-based therapies

Kumar, Dharmendra; Anand, Taruna; Talluri, Thirumala R.; Kues, Wilfried August GND

Induced pluripotent stem (iPS) cells present a seminal discovery in cell biology and promise to support innovative treatments of so far incurable diseases. To translate iPS technology into clinical trials, the safety and stability of these reprogrammed cells needs to be shown. In recent years, different non-viral transposon systems have been developed for the induction of cellular pluripotency, and for the directed differentiation into desired cell types. In this review, we summarize the current state of the art of different transposon systems in iPS-based cell therapies.

Preview

Cite

Citation style:

Kumar, Dharmendra / Anand, Taruna / Talluri, Thirumala / et al: Potential of transposon-mediated cellular reprogramming towards cell-based therapies. 2020.

Rights

Use and reproduction:

Export